Differences in the blood serum levels of soluble HLA-G concentrations between the menstrual cycle phases and menopause in patients with ovarian endometriosis and uterine leiomyoma

Neuroendocrinology Letters

Volumn 30, Issue 1, 2009, Pages 91-98

  Basta, Pawel ^a   Mach, Pawel ^a   Pitynski, Kazimierz ^a   Bednarek, Wieslawa ^b   Klimek, Marek ^a   Zietek, Jerzy ^c   Zajac, Krzysztof ^a   Wicherek, Lukasz ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Menstruation; Ovarian endometriosis; sHLA G; Uterine leiomyoma

Indexed keywords

HLA G ANTIGEN;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE MARKER; ENDOMETRIOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREGULATION; LAPAROTOMY; MAJOR CLINICAL STUDY; MENOPAUSE; MENSTRUAL CYCLE; POSTMENOPAUSE; UTERUS MYOMA;

ADULT; CASE-CONTROL STUDIES; ENDOMETRIOSIS; ESTRADIOL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; LEIOMYOMA; MENOPAUSE; MENSTRUAL CYCLE; MIDDLE AGED; OVARIAN DISEASES; PROGESTERONE; SOLUBILITY; UTERINE NEOPLASMS;

EID: 65349179097     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R: A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990; 248: 220-3.
2. Pistoia V, Morandi F, Wang X, Ferrone S. Soluble HLA-G: Are they clinically relevant?. Semin Cancer Biol 2007; 17: 469-79.
3. Rebmann V, Regel J, Stolke D, Grosse-Wilde H: Secretion of sHLA-G molecules in malignancies. Semin Cancer Biol 2003; 13: 371-7.
4. Brenner RM: Basic and applied biology of the primate reproductive tract - a symposium in honor of the career of Dr Robert M Brenner: introduction and overview. Reprod Biol Endocrinol 2006; 4 Suppl 1: S2
5. Rebmann V, Wagner S, Grosse-Wilde H: HLA-G expression in malignant melanoma. Semin Cancer Biol 2007; 17: 422-9.
6. Urosevic M, Kurrer MO, Kamarashev J, Mueller B, Weder W, Burg G, Stahel RA, Dummer R, Trojan A: Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol 2001; 159: 817-24.
7. Davidson B, Elstrand MB, McMaster MT, Berner A, Kurman RJ, Risberg B, Trope CG, Shih leM: HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma. Gynecol Oncol 2005; 96: 42-7
8. Singer G, Rebmann V, Chen YC, Liu HT, AN SZ, Reinsberg J, McMaster MT, Pfeiffer K, Chan DW, Wardelmann E, Grosse-Wilde H, Cheng CC, Kurman RJ, Shih leM. HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res 2003; 9: 4460-4.
9. Lindaman A, Dowden A, Zavazava N: Soluble HLA-G molecules induce apoptosis in natural killer cells. Am J Reprod Immunol 2006; 56: 68-76.
10. Kapasi K, Albert SE, Yie S, Zavazava N, Librach CL: HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology 2000; 101: 191-200.
11. Fournel S, Aguerre-Girr M, Hue X, Lenfant F, Alam A, Toubert A, Bensussan A, Le Bouteiller P: Cutting edge: soluble HLA-G1 triggers CD95/ CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000; 164: 6100-4.
12. Solier C, Aguerre-Girr M, Lenfant F, Campan A, Berrebi A, Rebmann V, Grosse-Wilde H, Le Bouteiller P: Secretion of proapoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. Eur J Immunol 2002; 32: 3576-86.
13. Wiendl H, Feger U, Mittelbronn M, Jack C, Schreiner B, Stadelmann C, Antel J, Brueck W, Meyermann R, Bar-Or A, Kieseier BC, Weller M: Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Brain 2005; 128: 2689-704.
14. Verbruggen LA, Rebmann V, Demanet C, De Cock S, Grosse-Wilde H: Soluble HLA-G in rheumatoid arthritis. Hum Immunol 2006; 67: 561-7.
15. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED: Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A 2001; 98: 12150-5.
16. Eidukaite A, Tamosiunas V: Soluble HLA-G in the peritoneal fluid of women with endometriosis. Fertil Steril 2008; 89: 465-7.
17. Kawashima M, Maeda N, Adachi Y, Takeuchi T, Yamamoto Y, Izumiya C, Hayashi K, Furihata M, Udaka K, Fukaya T. Human leukocyte antigen-G, a ligand for the natural killer receptor KIR2DL4, is expressed by eutopic endometrium only in the menstrual phase. Fertil Steril. 2009; 91(2): 343-9.
18. Barrier BF, Kendall BS, Ryan CE, Sharpe-Timms KL: HLA-G is expressed by the glandular epithelium of peritoneal endometriosis but not in eutopic endometrium. Hum Reprod 2006; 21: 864-9.
19. Wang F, Wen Z, Li H, Yang Z, Zhao X, Yao X: Human leukocyte antigen-G is expressed by the eutopic and ectopic endometrium of adenomyosis. Fertil Steril 2007
20. Carosella ED, Moreau P, Le Maoult J, Le Discorde M, Dausset J, Rouas-Freiss N: HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 2003; 81: 199-252.
21. Ishitani A, Geraghty DE: Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A 1992; 89: 3947-51
22. Rouas-Freiss N, Naji A, Durrbach A, Carosella ED: Tolerogenic functions of human leukocyte antigen G: from pregnancy to organ and cell transplantation. Transplantation. 2007; 84: S21-5.
23. Yang Y, Chu W, Geraghty DE, Hunt JS: Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma. J Immunol 1996; 156: 4224-31.
24. Gmyrek GB, Sieradzka U, Goluda M, Gabrys M, Sozanski R, Jerzak M, Zbyryt I, Chrobak A, Chetmonska-Soyta A: Flow cytometric evaluation of intracellular cytokine synthesis in peripheral mononuclear cells of women with endometriosis. Immunol Invest 2008; 37: 43-61.
25. Khan KN, Masuzaki H, Fujishita A, Kitajima M, Sekine I, Ishimaru T: Differential macrophage infiltration in early and advanced endometriosis and adjacent peritoneum. Fertil Steril 2004; 81: 652-61.
26. Gmyrek GB, Sieradzka U, Goluda M, Gabryś M, Sozański R, Jerzak M, Zbyryt I, Chrobak A, Chełmońska-Soyta A: Differential flow cytometric detection of intracellular cytokines in peripheral and peritoneal mononuclear cells of women with endometriosis. Eur J Obstet Gynecol Reprod Biol 2008; 137: 67-76.
27. Miura S, Khan KN, Kitajima M, Hiraki K, Moriyama S, Masuzaki H, Samejima T, Fujishita A, Ishimaru T: Differential infiltration of macrophages and prostaglandin production by different uterine leiomyomas. Hum Reprod 2006; 21: 2545-54.
28. Salamonsen LA, Zhang J, Brasted M: Leukocyte networks and human endometrial remodelling. J Reprod Immunol 2002; 57, 95-108.
29. Salamonsen LA: Current concepts of the mechanisms of menstruation: a normal process of tissue destruction. TEM 1998; 9, 305-309.
30. Ugur Y, Cakar AN, Beksac MS, Dagdeviren A: Activation Antigens during the Proliferative and Secretory Phases of Endometrium and Early-Pregnancy Decidua. Gynecol Obstet Invest 2006; 62: 66-74.
31. Weiss A, Goldman S, Shalev E: The matrix metalloproteinases (MMPS) in the decidua and fetal membranes. Front Biosci 2007; 12: 649-659.
32. Wicherek L: The role of the endometrium in the regulation of immune cell activity. Front Biosci 2008; 13: 1018-1035.
33. Dutsch-Wicherek M, Sikora J, Tomaszewska R: The possible biological role of metalothionein in apoptosis. Front Biosci 2008; 13: 4029-4038;
34. Popiela TJ, Klimek M, Wicherek L, Dutsch-Wicherek M, Galazka K, Rudnicka-Sosin L: The characterization of the exposure to immune mediated apoptosis and the regulation of immune cytotoxic activity in the environment of a neoplasm and in decidua. Neuro Endocrinol Lett 2006; 27: 779-785.
35. Skret-Magierlo J, Wicherek L, Basta P, Galazka K, Sikora J, Wilk M, Fudali L, Skret A: RCAS1 Decidual Immunoreactivity during Cesarean Section in Scar Deciduosis: Immune Cell Presence and Activity. Gynecol Obstet Invest 2007; 65: 187-194.
36. Wicherek L, Galazka K, Lazar A: RCAS1 Decidual Immunoreactivity During Placental Abruption: Immune Cell Presence and Activity. Am J Reprod Immunol 2007; 58: 46-55.
37. Wicherek L, Basta P, Sikora J, Galazka K, Rytlewski K, Grabiec M, Lazar A, Kalinka J. RCAS1 decidual immunoreactivity in severe pre-eclampsia: immune cell presence and activity. Am J Reprod Immunol 2007; 58: 358-366.
38. Wicherek L, Galazka K, Lazar A: The analysis of Metallothionein, RCAS1 immunoreactivity regarding immune cells concentration in endometrium and tubal mucosa in ectopic pregnancy during the course of tubal rupture. Gynecol Obstet Invest 2007,65: 52-61.
39. Wicherek L: Alterations in RCAS1 Serum Concentration Levels during the Normal Menstrual Cycle and the Lack of Analogical Changes in Ovarian Endometriosis. Am J Reprod Immunol 2008; 59; 535-544.
40. Dutsch-Wicherek M, Wicherek L: The Association of RCAS1 Serum Concentration with the Reversibility or Irreversibility of the Process of Immune Cytotoxic Activity Restriction during Normal Menstrual Cycle, Cancer Relapse, and Surgical Treatment for Various Types of Squamous Cell Carcinomas and Adenocarcinomas. Am J Reprod Immunol 2008; 59: 266-275.
41. Hornung D, Fujii E, Lim KH, Vigne JL, McMaster MT, Taylor RN: Histocompatibility leukocyte antigen-G is not expressed by endometriosis or endometrial tissue. Fertil Steril 2001; 75: 814-7.
42. Moreau P, Adrian-Cabestre F, Menier C, Guiard V, Gourand L, Dausset J, Carosella ED, Paul P: IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol 1999; 11: 803-11.
43. Lefebvre S, Moreau P, Guiard V, Ibrahim EC, Adrian-Cabestre F, Menier C, Dausset J, Carosella ED, Paul P: Molecular mechanisms controlling constitutive and IFN-gamma-inducible HLA-G expression in various cell types. J Reprod Immunol 1999; 43: 213-24.
44. King A, Burrows T, Loke YW: Human uterine natural killer cells. Nat Immun 1996; 15: 41-52.
45. Chen R, Alvero AB, Silasi DA, Mor G: Inflammation, cancer and chemioresistance: taking advantage of the Toll-like receptor signalling pathway. Am J Reprod Immunol 2007: 57; 93-107.
46. Pollard JW: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004; 4: 71-8.
47. Lin EY, Pollard JW: Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res 2007; 67: 5064-6.
48. Condeelis J, Pollard JW: Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006; 124: 263-6.
49. Lin EY, Pollard JW: Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer 2004; 90: 2053-8.
50. Malyshkina AI, Posiseeva LV, Sotnikova NY, Antsiferova JS, Suvorkina EE, Arevadze IE: Local immunological markers of different rate of growth of uterine myoma. Russ J Immunol 2002; 7: 58-62.